Insomnia Market to See Further Decline in Value, Expects GlobalData in Its Report Published at MarketPublishers.com
28 Oct 2016 • by Natalie Aster
LONDON – The most common sleep disorder globally, insomnia is estimated to hit up to 35% of the population.
In terms of etiology, cases of this disorder can be classified into primary and secondary subtypes. Being widely genericized, this market makes up competitive environment relative to new products.
Though a number of novel agents have been launched, the treatment algorithms focuses on low-dose sedating antidepressants and nonbenzodiazepines available in generic formulations.
The insomnia market is set to witness a further decline in its value following the loss of the top selling drug two years ago. However, this market also has some growth opportunities due to upcoming launch of two pipeline products which will address some needs that are currently unmet.
In-demand research report “Insomnia - 5EU Drug Forecast and Market Analysis to 2023” drawn up by GlobalData offers a comprehensive guide to the insomnia marketplace across to 5 EU markets. The study starts with an all-round overview of this disease including details on its symptoms, prognosis, classification, and more.
It throws light on the insomnia management and covers its management in key countries, such as the UK, Spain, Italy, etc. The report concentrates on the competitive landscape and looks at major brands as well as other therapeutic factors.
The research study discusses unmet needs and opportunities and comprises the pipeline assessment. It scrutinizes performance of this marketplace across key countries. The research report highlights drivers and barriers for each country market. Future outlook through 2023 is on hand in the study, too.
- overview of the disease;
- valuable data on major drugs;
- sales forecasts;
- insights into driving forces and barriers;
- future outlook;
- and more.
Other Marketplaces Examined in the Study Comprise:
- Fetal Monitors
- Bone Growth Stimulators
- Guillain-Barre Syndrome
- Mammography Equipment
- Portugal Orthopedic Power Tools
More insightful report by GlobalData can be found at its page.
Please note that now you have a chance to benefit from the end-of-year offer available for our customers. The offers ends on December 31, 2016.